Next Article in Journal
Impacts of Chitosan Coating on Shelf Life and Quality of Ready-to-Cook Beef Seekh Kabab During Refrigeration Storage
Next Article in Special Issue
Cassava Fiber Prevents High-Fat Diet-Induced Obesity in Mice Through Gut Microbiota Restructuring
Previous Article in Journal
Nanofiber-Enabled Rapid and Non-Destructive Sensors for Meat Quality and Shelf-Life Monitoring: A Review
Previous Article in Special Issue
Optimization of Gluten-Free Bread Formulation Using Whole Sorghum-Based Flour by Response Surface Methodology
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 14
Issue 22
10.3390/foods14223843
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes

by
Xiaofei Zhou
1,
Tianxu Liu
2,
Bingye Xu
2,
Weiqian Zhang
2,
Xiang Li
2,
Fan Wei
2,
Huan Lv
2,
Xuemeng Ji
2,
Bowei Zhang
2,* and
Shuo Wang
2,*
1
Institute of Biomaterials and Biomedicine, School of Food and Pharmacy, Shanghai Zhongqiao Vocational and Technical University, Shanghai 201514, China
2
Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, China
*
Authors to whom correspondence should be addressed.
Foods 2025, 14(22), 3843; https://doi.org/10.3390/foods14223843
Submission received: 6 October 2025 / Revised: 3 November 2025 / Accepted: 6 November 2025 / Published: 10 November 2025
(This article belongs to the Special Issue Functional Foods, Gut Microbiota, and Health Benefits)
Browse Figures
Review Reports Versions Notes

Abstract

Dandelion is an edible and medicinal plant that has beneficial effects in various complex disorders. In this study, we investigated the regulatory effects of dandelion leaf aqueous extract (DAE) on mice with hyperuricemia (HUA) and explored its underlying mechanisms. DAE exhibited a high total phenolic content (363.31 ± 0.61 mg GAC/g) and contained 20 identified polyphenolic compounds. The administration of DAE significantly reduced serum uric acid levels and exerted protective effects on both liver and kidney function in mice with HUA. Mechanistically, DAE inhibited the NLRP3/Caspase-1 and TLR4/MyD88/NF-κB signaling pathways, leading to the downregulated mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), thereby alleviating renal inflammation. Additionally, DAE modulated the gut microbiota composition and increased SCFA-producing bacteria, along with increases in fecal SCFA contents. These findings suggest that DAE effectively mitigates HUA and its associated renal complications by regulating uric acid metabolism, suppressing renal inflammation, and restoring gut microbial homeostasis. Thus, DAE holds promise as a natural adjuvant therapy for HUA and related kidney inflammation.

1. Introduction

Hyperuricemia (HUA) is a prevalent metabolic disorder with an increasing global incidence. It is closely associated with various diseases, including gout, chronic kidney disease, cardiovascular disorders, diabetes mellitus, nonalcoholic fatty liver disease, and metabolic syndrome [1].
Xanthine oxidase (XOD), which catalyzes the oxidation of hypoxanthine to xanthine and ultimately to uric acid, is a critical enzyme for the uric acid synthesis [2]. Elevated XOD activity leads to abnormal purine metabolism and excessive uric acid production, resulting in elevated SUA levels [3]. In addition, the insufficient elimination of uric acid is also responsible for the onset of HUA [4]. Urate disposal depends primarily on the urate transport system, including uric acid reuptake and secretory transport. The increased expression of reuptake proteins such as glucose transporter type 9 (GLUT9) enhances uric acid reabsorption, whereas the decreased expression of secretory proteins (e.g., organic anion transporter 1 (OAT1), OAT2, and ATP-binding cassette transporter G2 (ABCG2)) reduces uric acid excretion, collectively contributing to HUA [5,6].
Crystallized urate deposited in the kidney will activate the NOD-like receptor superfamily pyrin domain-containing 3 (NLRP3) inflammasome and regulate the Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and nuclear factor-κB (NF-κB) signaling pathways, which will lead to kidney damage [7].
Recently, several studies have posited that gut microbes are related to the onset of HUA [8,9]. Animals with HUA have altered gut microbiota composition and metabolites, short-chain fatty acids (SCFAs) in particular [10,11]. SCFAs have been reported to be beneficial to kidney function [12]. Moreover, several studies have pointed out that HUA relief is associated with the upregulation of SCFA contents [10,11]. Hence, the gut microbiota and metabolite SCFAs may be essential targets to cure HUA.
Uric acid-lowering therapies are segmented into two major categories. One is the XOD inhibitor typical of allopurinol, which inhibits the generation of uric acid via the competitive inhibition of XOD. The other is uricosuric drugs such as probenecid and benzbromarone, which promote uric acid elimination by hindering urate reabsorption in the renal tubule [13]. However, the use of these drugs is usually associated with some undesirable side effects (e.g., hepatic and renal toxicity, bone marrow suppression, and gastrointestinal irritation) [14,15]. Therefore, there is an urgent need to develop effective, low-toxicity, plant-based interventions that target multiple pathways involved in HUA pathogenesis.
Dandelion (Taraxacum officinale L.), a medicinal and edible plant, has been employed for treating spleen and liver complaints, kidney ailments, and gallbladder disorders for centuries [16,17]. Recently, polyphenols have been the focus of interventions for HUA and kidney inflammation [18,19,20]. Dandelion contains various polyphenols, including quercetin, luteolin, chlorogenic acid, caffeic acid, hesperidin, vanillin, etc. [21]. Meanwhile, a previous study demonstrated that dandelion root extract significantly decreased SUA [22]. However, none of the literature has focused on the uric acid-lowering and kidney inflammation relief effects of dandelion leaves. Hence, in this experiment, we sought to elucidate the role of dandelion leaf aqueous extract (DAE) against HUA and its complications and explored its underlying mechanisms, particularly regarding renal inflammation and gut microbiota regulation.

2. Materials and Methods

2.1. Materials and Reagents

Potassium oxonate (PO) was obtained from Sigma-Aldrich. Folin–Ciocalteu reagent, XOD (5 U/450 µL), xanthine, and carboxymethyl cellulose sodium salt (CMC-Na) were purchased from Solarbio Co., Ltd. (Beijing, China). Hypoxanthine (HX) was supplied by Aladdin Reagent Co. (Shanghai, China), and commercial assay kits for SUA, creatinine (Cr), blood urea nitrogen (BUN), ALT, AST, and XOD activity were procured from Jian Cheng Bioengineering Institute (Nanjing, China). Methanol and formic acid (HPLC grade) were purchased from Thermo Fisher Technology Co., Ltd. (Shanghai, China), and dried dandelion leaves were purchased from the market (Bozhou, China).

2.2. Preparation of DAE

Dried dandelion leaves were ground into a fine powder using a knife mill (FRITSCH, Stuttgart, Germany). Then, 50 g of the powder was extracted with distilled water at a ratio of 1:30 (w/v) for 2 h at 100 °C. The supernatant was obtained by suction filtration, concentrated by vacuum depression vaporization at 70 °C, freeze-dried, and kept at −80 °C until further use. The yield percentage of the extract was calculated as (weight of freeze-dried powder/weight of dried leaves) × 100%. The extraction yield of DAE was 29.22 ± 0.53% (n = 3).

2.3. The Measurement of the Total Phenolic Content (TPC)

The TPC of DAE was determined using the Folin–Ciocalteu colourimetric method [23], with results expressed as mg GAC equivalents per gram DAW (mg GAC/g).

2.4. Ultra-High-Performance Liquid Chromatography Coupled with Hybrid Quadrupole–Orbitrap Mass Spectrometry (UHPLC/Orbitrap-MS)

A total of 100 mg of the sample was extracted with 1 mL of 80% methanol (v/v) for 10 min by a vortex. After centrifugation at 12,000 rpm for 10 min, the supernatant was filtered through a 0.22 μm membrane for MS analysis. Then, 5 µL of the extract was injected into a UHPLC–Orbitrap–MS/MS system. Samples were separated using an AQ C18 column (1.8 μm, 2.1 mm × 150 mm). Mobile phase (A) was methanol, and mobile phase (B) was water containing formic acid (0.1%, v/v). A non-linear gradient was adopted (Table S1), and the column temperature was kept at 35 °C. Mass spectra were acquired in both positive and negative ionization modes.

2.5. Determination of XOD Inhibition In Vitro

The inhibitory effect of DAE on xanthine oxidase activity was assessed spectrophotometrically at 295 nm, using xanthine as the substrate, according to a previously described method [24].

2.6. Animals and Hyperuricemia Models

Twenty-four male Kunming mice were obtained from Vital River Laboratories (Beijing, China) (SCXK (JING) 2016-0011). Animals were housed under standard laboratory conditions (24 ± 2 °C, 50 ± 5% humidity, 12 h light/dark cycle) with ad libitum access to standard rodent chow and water. All experimental procedures were strictly approved by the Ethics Committee of Tianjin University of Science and Technology.
HX and PO, dissolved in saline and CMC-Na, respectively, were applied to induce the HUA mice model. The mice were randomized and divided into a normal control group (NC, n = 8), a hyperuricemia group (MC, n = 8), and a DAE group (DAE, n = 8). Except for the NC group, mice were injected with HX (intraperitoneally, 300 mg/kg) and PO (intragastrically, 300 mg/kg) daily at 9:00 a.m. One hour later, mice in the DAE group received 1 g/kg of DAE by oral gavage for 19 consecutive days. Based on the body surface area conversion method, the dose is equivalent to a daily intake of 15 g of dandelion leaves for adults, which aligns with the recommendations of the Chinese Pharmacopoeia [25].
Finally, mice were deprived of food for 12 h before euthanasia, with distilled water still available. Blood samples were collected and centrifuged at 1000× g for 10 min at 4 °C to obtain serum. Liver and kidney tissues were excised, rinsed with cold saline, blotted dry, and weighed before being split into two parts. A part of the tissue was fixed in formalin for histopathological examination, and the rest was kept at −80 °C for further study.

2.7. Measurement of Biochemical Indicators in Serum and Liver of Mice

Serum was obtained to detect SUA, AST, ALT, BUN, and Cr levels. Liver tissues were homogenized to detect XOD activity. All steps were performed to abide by the manufacturer’s instructions.

2.8. RT-qPCR Analysis

Total RNA extraction, cDNA synthesis, and RT-PCR quantitation were performed in accordance with our previous method [26]. Primers provided by GENEWIZ (Suzhou, China) are shown in Supplementary Table S2. Relative mRNA expression was evaluated through the 2−ΔΔCt method after being normalized to β-actin.

2.9. Histological Examination

Liver and kidney samples fixed with formalin were gradually dehydrated with ethanol, clarified with xylene, embedded in paraffin, sectioned, and stained with haematoxylin and eosin (H&E) for microscopy observation at 200× magnification.

2.10. Determination of SCFA Content

The SCFA content was detected using our previous method [26].

2.11. Gut Microbiota Analysis

Fecal DNA was extracted with commercial extraction kits (Magen, Guangzhou, China). The V3-V4 region of the bacterial 16S rRNA gene was amplified using a previously described method [27]. A principal coordinate analysis (PCoA) and the creation of a stacked bar plot of the bacteria composition were achieved using the R project. Circular layout representations of species abundance were generated using Circos software v.2. The KEGG pathway analysis of the OTUs was inferred using Tax4Fun v.0.69.

2.12. Statistical Analysis

All data were examined using a one-way analysis of variance (ANOVA) and the Duncan test (SPSS 23.0). The results are presented as mean ± standard error values of at least six repetitions unless otherwise stated.

3. Results

3.1. Determination of TPC and Identification of Polyphenol Compounds in DAE

The TPC of DAE was determined to be 363.04 ± 3.16 mg GAC/g. The phytochemical composition of DAE was further identified with a mass analysis and MS2 fragmentation. Figure 1 illustrates that, using the mass spectrometer, the ion flow with the positive and negative ion mode scan demonstrated better responses. Twenty polyphenol compounds in total were identified in DAE (Table 1). Among them, benzoic acid, chlorogenic acid, caffeic acid, ferulic acid, caffeoylquinic, quinic acid, tartaric acid, luteolin, and diosmetin are reported to be common in dandelion [28,29].

3.2. DAE Decreased SUA and Modulated Physical Signs in Mice with HUA

Compared with the NC group (34 µmol/L, Figure 2A), SUA levels significantly increased up to 282 µmol/L (p < 0.01) in the MC group, which further confirmed the effectiveness of the modeling method. The DAE treatment decreased the levels of SUA to 124 µmol/L (p < 0.01) in the mice with HUA, indicating a strong hypouricemic effect.
Body weight and organ coefficients directly reflect the health status of the mice. As shown in Figure 1B, there was no statistical difference in initial body weights in different groups. After the modeling, the weight of the mice was significantly decreased (p < 0.01, Figure 2B) compared with the NC group. However, the DAE treatment restored the body weight to normal levels. Additionally, the liver and kidney coefficients of the mice with HUA were increased significantly compared with the NC group (p < 0.01, Figure 2C,D). However, DAE administration significantly decreased the organ coefficients, reflecting improved organ health and systemic recovery.

3.3. DAE Alleviated Liver Injury in Mice with HUA

To further evaluate the hepatoprotective effects of DAE, ALT and AST activities were measured. A significant increase in enzyme activity was observed in the MC group (15.52, 20.67 U/L) compared with that in the NC mice (12.51, 13.84 U/L) (Figure 3A,B). As expected, DAE significantly decreased the AST and ALT activity to 9.89 and 16.30 U/L, respectively (p < 0.05). This result indicates that DAE alleviated the liver injury in the mice with HUA.
H&E staining was performed to further confirm the hepatic protection effect of DAE (Figure 3E). In the NC group, the hepatic lobule was centered on the central vein, surrounded by roughly radially arranged hepatocytes and hepatic blood sinusoids. The hepatocytes were round and full. The liver plate was arranged regularly and neatly, and there was no evident expansion or compression of the liver sinus. The portal area between the adjacent hepatic lobules was not abnormal. No significant inflammatory cell infiltration was observed. In the MC group, there was minimal focal necrosis of hepatocytes surrounding the central vein (black arrow) with the focal infiltration of inflammatory cells (red arrow). These pathological changes were markedly attenuated in the DAE-treated group, confirming the protective effect of DAE against HUA-induced liver damage.

3.4. DAE Alleviated Kidney Damage in Mice with HUA

Compared with the NC group, BUN and CR levels in the MC group were significantly increased by approximately 89.9% and 37.2%, respectively (p < 0.01). However, in the DAE group, we also noted a remarkable decrease in the BUN level with a reduction of 15.0% (p < 0.01) and the CR level with a reduction of 28.6% (p < 0.01) (Figure 3C,D), suggesting improved kidney function.
To further confirm the renal protection effect of DAE, we performed H&E staining of kidney sections (Figure 3F). In the NC group, the glomerulus was evenly distributed, and the number of cells and the matrix in the glomerulus were uniform. The epithelial cells of renal tubules were round, complete, and tightly arranged, and there was no apparent interstitial hyperplasia. No significant inflammatory changes were observed. In the MC group, however, there was a small amount of local perivascular connective tissue hyperplasia with a small amount of inflammatory cell infiltration (blue arrow). As expected, there was no apparent difference between the DAE and the NC groups. The results demonstrated that DAE effectively mitigates HUA-induced renal injury.

3.5. DAE Decreased XOD Activities Both In Vitro and In Vivo

The in vitro XOD activity was significantly decreased by DAE in a dose-dependent manner (Figure 4A). The in vivo liver XOD activity in the MC mice was 25.3% higher than the NC mice (p < 0.01, Figure 4B). However, DAE effectively decreased 14.9% of this (p < 0.01). The results indicate that DAE decreases SUA levels by inhibiting the XOD activity.

3.6. DAE Modulated the mRNA Expression of GLUT9, OAT1, OAT2, and ABCG2

GLUT9 is one of the most vital uric acid transporters responsible for urate reabsorption [30]. Compared with the NC group, the mRNA expression of GLUT9 exhibited a significant elevation in the MC group (p < 0.05, Figure 4C). However, the DAE treatment restored the mRNA level in the NC group (p < 0.05). OAT1, OAT2, and ABCG2 are common uric acid excretion proteins [31]. Transcription expressions of renal OAT1, OAT2, and ABCG2 were significantly reduced compared with the NC group (p < 0.01) (Figure 4D–F). However, the treatment with DAE partly restored their transcription levels (p < 0.05). ABCG2 is also expressed in the gut, especially in the ileum [6]. Hence, the mRNA expression of ileal ABCG2 was detected. It exhibited the same tendency as the results of the renal ABCG2 expression (Figure 4G). These results demonstrate that DAE lowered SUA levels by regulating the mRNA expression of uric acid transporters.

3.7. DAE Decreased the mRNA Expression of Renal Inflammation Cytokines and Inhibited the TLR4/MyD88/NF-κB and the NLRP3/Caspase-1 Signaling Pathways in Mice with HUA

In the present study, renal transcriptional expressions of inflammatory cytokines were determined. Figure 5A–C show that compared with the NC group, renal IL-6, IL-1β, and TNF-α mRNA expressions were significantly elevated in the MC group (p < 0.01). As expected, the mRNA levels of these inflammatory cytokines significantly decreased and were similar to the NC group after the DAE treatment (p < 0.05).
TLR4/MyD88/NF-κB and NLRP3/Caspase-1 are critical signaling pathways closely associated with inflammation, mediating inflammatory cytokines such as IL-6, TNF-α, and IL-1β. Figure 5D–H demonstrate that the mRNA expression of NLRP3, Caspase-1, TLR4, MyD88, and NF-κB was significantly increased in the MC group compared with the NC group (p < 0.01). Instead, DAE significantly reduced the mRNA expression of all these inflammation factors (p < 0.05). These findings suggest that DAE alleviates HUA-induced kidney injury by regulating the NLRP3 pathway and TLR4/MyD88/NF-κB pathway, thereby decreasing the mRNA expression of inflammatory cytokines in mice with HUA.

3.8. DAE Modulated Gut Microbe Disorder in Mice with HUA

16S rRNA sequencing was used to determine the impact of DAE supplementation on the gut microbiota of mice with HUA. The principal coordinate analysis (PCoA) analysis indicated that samples from different groups exhibited distinctive microbiota structures (Figure 6A). At the phylum level, Firmicutes and Bacteroidetes made up over 90% of the microbiota (Figure 6B). The relative abundance of Firmicutes and Proteobacteria significantly increased, and Bacteroidetes were significantly reduced in the MC group when compared with the NC group. By contrast, the DAE treatment significantly reversed these changes (p < 0.05, Figure S1A,B). At the genus level, Lactobacillus accounted for the most (Figure 6C). The relative abundances of Alloprevotella, Alistipes, and Bacteroides were reduced, while Lactobacillus, Helicobacter, and Lachnospiraceae UCG-006 were increased in the MC group. However, DAE treatment also reversed these changes (Figure S1C–E). The linear discriminant analysis (LDA) and effect size (LEfSe) analysis further identified 23 influential taxonomic clades in total. In particular, Lactobacillus and its related species were enriched in the MC group (Figure 6D,E).
In the Tax4Fun functional analysis, the KEGG pathway related to nucleotide metabolism, specifically purine metabolism, was increased after modeling, while the treatment with DAE reversed this effect (Figure 6F,G).

3.9. DAE Upregulated SCFA Content in Mice with HUA

Compared with the NC group, the contents of acetic acid, propionic acid, and butyric acid in the MC group were significantly reduced by 27.2%, 31.3%, and 37.4%, respectively. After the administration of DAE, the contents of three SCFAs increased (Figure 7).

3.10. Correlation Analysis of Gut Microbiota with SCFAs and HUA-Related Indicators

To further understand the association between the bacterial genus and related indicators, a Pearson correlation analysis was performed (Figure 8). The results showed that Lactobacillus, Muribaculum, Helicobacter, and Lachnospiraceae UCG-006 were positively associated with HUA-related indicators, and they were negatively associated with SCFAs. By contrast, Alloprevotella, Bacteroides, and Alistipes were negatively associated with HUA-related indicators and positively associated with SCFAs.

4. Discussion

Nowadays, HUA morbidity and its complications have surged worldwide [32]. However, therapeutic agents are sometimes limited by undesirable side effects. There is, therefore, an urgent need for safe, multi-targeted, and naturally derived interventions. In the present study, we found that DAE effectively lowered SUA levels, reduced renal inflammation, and modulated the gut microbiota in mice with HUA.
The homeostasis of SUA is primarily determined by the balance between uric acid biosynthesis and excretion [33]. XOD is a vital enzyme in purine nucleotide metabolism [34]. When the XOD activity increases, it produces excessive uric acid. Our study demonstrated that DAE, which is rich in diverse polyphenolic compounds, exhibited a significant inhibitory effect on XOD activity in vitro in a dose-dependent manner. Consistent with this, the DAE treatment also significantly decreased hepatic XOD activity in mice with HUA. This indicates that the inhibition of the XOD activity is a key mechanism underpinning the hypouricemic action of DAE. While previous studies have focused on dandelion root extracts [22], our findings highlight the distinct efficacy of the leaf extract, which is notably abundant in polyphenols with recognized XOD inhibitory and anti-inflammatory properties.
Beyond diminishing the uric acid production, enhancing urate excretion can also reduce SUA. Uric acid is expelled from the body through both renal and intestinal pathways. GLUT9 at the apical membranes of the proximal renal tubules is responsible for the uric acid reabsorption in the kidney [35]. OAT1 and OAT2, located in the basolateral membrane, and ABCG2 at the apical membrane, have been considered to be dominant secretory urate transporters [18]. Our results showed that the mRNA expression of GLUT9 was significantly elevated, while that of OAT1, OAT2, and ABCG2 was significantly reduced in the MC group, which is consistent with the results of a previous study [36]. The DAE treatment efficiently decreased the mRNA expression of renal GLUT9 and upregulated renal OAT1, OAT2, and ABCG2, thereby promoting uric acid excretion via the kidneys. One-third of the uric acid in the body is excreted through the gut. Recently, research has confirmed that ABCG2, also expressed on the apical membrane in the intestine, is vital for the intestinal excretion of uric acid [37]. In this study, DAE significantly upregulated the decreased mRNA expression of ABCG2, resulting in increased uric acid excretion from the intestine. These findings suggest that DAE reduces uric acid levels by regulating the mRNA expression of uric acid transporters in both the kidney and intestines.
The inflammatory response is a critical pathologic feature of HUA [38]. This study confirms that HUA induces renal inflammation, and DAE exerts a mitigating effect on HUA-induced kidney injury. Uric acid stimulates the NLRP3 inflammasome, leading to IL-1β secretion and the activation of innate immune responses [39]. Moreover, the NF-κB signaling pathway is also crucial in HUA-induced renal inflammation [40,41]. NF-κB modulates the expression of pro-inflammatory cytokine IL-1β via Toll-like receptor (TLR) signaling, in which the cytosolic TLR adapter protein MyD88 is involved. Han et al. reported that tuna meat oligopeptides alleviated HUA-induced renal inflammation by blocking the TLR4/MyD88/NF-κB signaling pathway and NLRP3 inflammasome. Consistent with this finding, our study showed that the relief effects of DAE on HUA-induced renal injury are also mediated directly by inhibiting both the TLR4/MyD88/NF-κB and NLRP3/Caspase-1 signaling pathways.
HUA burdens the kidney and causes renal injury [42]. As kidney function declines, less uric acid is excreted through the kidneys. Subsequently, the increased uric acid in the blood circulation will be excreted through the gut to compensate, directly inducing changes in the gut microenvironment [36]. This finding aligns with previous reports of gut microbiota dysbiosis in HUA models [8,9,10,11]. Here, our finding that Firmicutes was significantly increased and Bacteroidetes was significantly reduced in mice with HUA is in accordance with previous studies [28,43]. By contrast, the DAE treatment significantly reversed these changes. Shin et al. have pointed out that increased Proteobacteria is a potential signature of dysbiosis [44]. In the present study, the relative abundance of Proteobacteria was significantly increased in the mice with HUA, while DAE significantly decreased it. This result further indicates that mice with HUA demonstrated a disordered gut microbiota, while DAE demonstrated regulatory effects on the gut microbiota composition. At the genus level, the relative abundances of Alloprevotella, Alistipes, and Bacteroides were decreased, while the human pathogen Helicobacter was increased in the mice with HUA. These results are consistent with the findings of our previous study [19]. However, the DAE treatment increased their abundances. Chen et al. found that Lachnospiraceae_UCG-006 was negatively connected with SCFA production [45], which is in accordance with our study. It is interesting that Lactobacillus was more abundant in the MC mice than the NC and DAE groups, which is the opposite of most studies’ findings but is consistent with the results of Huang [46]. What our study has in common with Huang’s animal models is the use of adenine. It has been reported that Lactobacillus may utilize adenine and stimulate proliferation [47]. In addition, nucleotide precursors can also promote the growth of Lactobacillus [48]. In line with this, the Tax4Fun analysis also showed that purine metabolism was increased in the MC group, but DAE decreased this. These results indicate that DAE influenced the abundance of Lactobacillus by interfering with the bioavailability of purine.
A bidirectional relationship exists between gut microbiota homeostasis and HUA [49]. In addition to the impact of HUA on the gut microbe composition, gut microbiota and their metabolites also play a critical role in the occurrence and development of HUA. Short-chain fatty acids (SCFAs) are gut microbiota metabolites. They have been reported to inhibit hepatic XO activity and reduce uric acid concentrations in vivo [50,51]. Moreover, SCFAs have been shown to be nephroprotective [12]. As SCFA-producing bacteria, Bacteroides, Alistipes, and Alloprevotella were reduced in the MC group. However, the DAE supplement increased the abundance of SCFA-producing bacteria (e.g., Bacteroides and Alistipes) and elevated fecal SCFA levels. Since SCFAs are known to inhibit xanthine oxidase activity and ameliorate renal inflammation, these changes are consistent with the observed reduction in SUA and renal protection.

5. Conclusions

In summary, this study provides comprehensive evidence for the therapeutic potential of DAE against HUA and its complications. DAE significantly lowered SUA in mice with HUA by inhibiting XOD activity, decreasing the mRNA expression of GLUT9, and increasing the mRNA expression of OAT1, OAT2, and ABCG2. Concurrently, it inhibited the mRNA expression of renal inflammatory cytokines via the inhibition of NLRP3/Caspase-1 and TLR4/MyD88/NF-κB signaling pathways, thereby alleviating the HUA-induced kidney inflammation. Moreover, DAE modulated the gut microbiota composition, enriched SCFA-producing bacteria, and elevated SCFAs levels, collectively contributing to its anti-hyperuricemic and nephroprotective effects.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/foods14223843/s1, Figure S1: Changes of gut microbiota at the phylum and genus levels. Relative abundance of Bacteroidetes, Firmicutes (A), and Proteobacteria (B). Relative abundance of Lactobacillus, Alloprevotella (C), Alistipes, Bacteroides (D), Helicobacter, and Lachnospiraceae UCG-006 (E). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group; Table S1: The gradient elution program of the mobile phase; Table S2: Primer sequences for RT-qPCR.

Author Contributions

X.Z., T.L., X.L. and F.W. conducted the animal experiments and drafted the manuscript; S.W., B.Z. and X.J. designed the research and performed critical revisions of the manuscript; B.X., W.Z. and H.L. analyzed the data. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Chenguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (24CGB24) and the School-Level Project of Shanghai Zhongqiao Vocational and Technical University (ZQZR202431).

Institutional Review Board Statement

All experimental procedures were strictly approved by the Ethics Committee of Tianjin University of Science and Technology (No. 2019030, approved on 27 September 2019).

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article and Supplementary Materials. Further inquiries can be directed to the corresponding authors.

Conflicts of Interest

There are no conflicts to declare.

References

  1. Kuo, D.; Crowson, C.S.; Gabriel, S.E.; Matteson, E.L. Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis. Int. J. Rheumatol. 2014, 2014, 523897. [Google Scholar] [CrossRef]
  2. Yan, J.; Zhang, G.; Hu, Y.; Ma, Y. Effect of luteolin on xanthine oxidase: Inhibition kinetics and interaction mechanism merging with docking simulation. Food Chem. 2013, 141, 3766–3773. [Google Scholar] [CrossRef]
  3. So, A.; Thorens, B. Uric acid transport and disease. J. Clin Investig. 2010, 120, 1791–1799. [Google Scholar] [CrossRef] [PubMed]
  4. Li, H.; Zhao, M.; Su, G.; Lin, L.; Wang, Y. Effect of Soy Sauce on Serum Uric Acid Levels in Hyperuricemic Rats and Identification of Flazin as a Potent Xanthine Oxidase Inhibitor. J. Agric. Food Chem. 2016, 64, 4725–4734. [Google Scholar] [CrossRef] [PubMed]
  5. Bian, M.; Du, X.; Wang, P.; Cui, J.; Xu, J.; Gu, J.; Zhang, T.; Chen, Y. Combination of ginsenoside Rb1 and Rd protects the retina against bright light-induced degeneration. Sci. Rep. 2017, 7, 6015. [Google Scholar] [CrossRef]
  6. Matsuo, H.; Nakayama, A.; Sakiyama, M.; Chiba, T.; Shimizu, S.; Kawamura, Y.; Nakashima, H.; Nakamura, T.; Takada, Y.; Oikawa, Y.; et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci. Rep. 2014, 4, 3755. [Google Scholar] [CrossRef]
  7. Jhang, J.J.; Lin, J.H.; Yen, G.C. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication. J. Agric. Food Chem. 2018, 66, 765–772. [Google Scholar] [CrossRef]
  8. Pan, L.; Han, P.; Ma, S.; Peng, R.; Wang, C.; Kong, W.; Cong, L.; Fu, J.; Zhang, Z.; Yu, H.; et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharm. Sin. B 2020, 10, 249–261. [Google Scholar] [CrossRef] [PubMed]
  9. Wu, Y.; Ye, Z.; Feng, P.; Li, R.; Chen, X.; Tian, X.; Han, R.; Kakade, A.; Liu, P.; Li, X. Limosilactobacillus fermentum JL-3 isolated from “Jiangshui” ameliorates hyperuricemia by degrading uric acid. Gut Microbes 2021, 13, 1897211. [Google Scholar] [CrossRef]
  10. Zhao, H.; Chen, X.; Zhang, L.; Meng, F.; Zhou, L.; Pang, X.; Lu, Z.; Lu, Y. Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis. Pharmacol. Res. 2022, 182, 106350. [Google Scholar] [CrossRef]
  11. Lu, C.; Tang, S.; Han, J.; Fan, S.; Huang, Y.; Zhang, Z.; Zhou, J.; Ming, T.; Li, Y.; Su, X. Apostichopus japonicus Oligopeptide Induced Heterogeneity in the Gastrointestinal Tract Microbiota and Alleviated Hyperuricemia in a Microbiota-Dependent Manner. Mol. Nutr. Food Res. 2021, 65, e2100147. [Google Scholar] [CrossRef]
  12. Gonzalez, A.; Krieg, R.; Massey, H.D.; Carl, D.; Ghosh, S.; Gehr, T.W.B.; Ghosh, S.S. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol. Dial. Transplant. 2019, 34, 783–794. [Google Scholar] [CrossRef] [PubMed]
  13. Suresh, E.; Das, P. Recent advances in management of gout. QJM Int. J. Med. 2012, 105, 407–417. [Google Scholar] [CrossRef]
  14. Ansari-Ramandi, M.M.; Maleki, M.; Alizadehasl, A.; Amin, A.; Taghavi, S.; Alemzadeh-Ansari, M.J.; Kazem Moussavi, A.; Naderi, N. Safety and effect of high dose allopurinol in patients with severe left ventricular systolic dysfunction. J. Cardiovasc. Thorac Res. 2017, 9, 102–107. [Google Scholar] [CrossRef][Green Version]
  15. Kim, S.C.; Neogi, T.; Kang, E.H.; Liu, J.; Desai, R.J.; Zhang, M.; Solomon, D.H. Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients with Gout. J. Am. Coll. Cardiol. 2018, 71, 994–1004. [Google Scholar] [CrossRef] [PubMed]
  16. Jędrejek, D.; Kontek, B.; Lis, B.; Stochmal, A.; Olas, B. Evaluation of antioxidant activity of phenolic fractions from the leaves and petals of dandelion in human plasma treated with H2O2 and H2O2/Fe. Chem. Biol. Interact. 2017, 262, 29–37. [Google Scholar] [CrossRef]
  17. Chen, H.J.; Inbaraj, B.S.; Chen, B.H. Determination of phenolic acids and flavonoids in Taraxacum formosanum Kitam by liquid chromatography-tandem mass spectrometry coupled with a post-column derivatization technique. Int. J. Mol Sci. 2012, 13, 260–285. [Google Scholar] [CrossRef] [PubMed]
  18. Qian, X.; Wang, X.; Luo, J.; Liu, Y.; Pang, J.; Zhang, H.; Xu, Z.; Xie, J.; Jiang, X.; Ling, W. Hypouricemic and nephroprotective roles of anthocyanins in hyperuricemic mice. Food Funct. 2019, 10, 867–878. [Google Scholar] [CrossRef]
  19. Ren, Q.; Cheng, L.; Guo, F.; Tao, S.; Zhang, C.; Ma, L.; Fu, P. Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation. J. Agric. Food Chem. 2021, 69, 10932–10942. [Google Scholar] [CrossRef]
  20. Hu, Q.H.; Zhang, X.; Wang, X.; Jiao, R.Q.; Kong, L.D. Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice. Eur. J. Nutr. 2012, 51, 593–606. [Google Scholar] [CrossRef]
  21. Tan, X.; Sun, Z.; Zhou, C.; Huang, Z.; Tan, L.; Xun, P.; Huang, Q.; Lin, H.; Ye, C.; Wang, A. Effects of dietary dandelion extract on intestinal morphology, antioxidant status, immune function and physical barrier function of juvenile golden pompano Trachinotus ovatus. Fish Shellfish Immunol. 2018, 73, 197–206. [Google Scholar] [CrossRef] [PubMed]
  22. Khallawi, K.M.; Hameed, B.J.; Neamah, N.F. Uricosuric effect of dandelion root extract on oxonate-induced hyperuricemia in rats. Ukr. J. Nephrol. Dial. 2023, 3, 14–22. [Google Scholar] [CrossRef]
  23. Kim, D.W.; Curtis-Long, M.J.; Yuk, H.J.; Wang, Y.; Song, Y.H.; Jeong, S.H.; Park, K.H. Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC-ESI MS/MS and their xanthine oxidase inhibition. Food Chem. 2014, 153, 20–27. [Google Scholar] [CrossRef]
  24. Zhou, J.; Li, P.; Cheng, N.; Gao, H.; Wang, B.; Wei, Y.; Cao, W. Protective effects of buckwheat honey on DNA damage induced by hydroxyl radicals. Food Chem. Toxicol. 2012, 50, 2766–2773. [Google Scholar] [CrossRef]
  25. Committee National Pharmacopoeia. Pharmacopoeia of People’s Republic of China, 2020th ed.; China Medial Science Press: Beijing, China, 2020; pp. 123–129. [Google Scholar]
  26. Zhou, X.; Zhang, B.; Zhao, X.; Lin, Y.; Zhuang, Y.; Guo, J.; Wang, S. Chlorogenic Acid Prevents Hyperuricemia Nephropathy via Regulating TMAO-Related Gut Microbes and Inhibiting the PI3K/AKT/mTOR Pathway. J. Agric. Food Chem. 2022, 70, 10182–10193. [Google Scholar] [CrossRef]
  27. Zhou, X.; Zhang, B.; Zhao, X.; Lin, Y.; Wang, J.; Wang, X.; Hu, N.; Wang, S. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Food Funct. 2021, 12, 5637–5649. [Google Scholar] [CrossRef]
  28. Martinez, M.; Poirrier, P.; Chamy, R.; Prüfer, D.; Schulze-Gronover, C.; Jorquera, L.; Ruiz, G. Taraxacum officinale and related species-An ethnopharmacological review and its potential as a commercial medicinal plant. J. Ethnopharmacol. 2015, 169, 244–262. [Google Scholar] [CrossRef]
  29. Miłek, M.; Marcinčáková, D.; Legáth, J. Polyphenols Content, Antioxidant Activity, and Cytotoxicity Assessment of Taraxacum officinale Extracts Prepared through the Micelle-Mediated Extraction Method. Molecules 2019, 24, 1025. [Google Scholar] [CrossRef]
  30. Kimura, T.; Takahashi, M.; Yan, K.; Sakurai, H. Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells. PLoS ONE 2014, 9, e84996. [Google Scholar] [CrossRef]
  31. Sun, H.L.; Wu, Y.W.; Bian, H.G.; Yang, H.; Wang, H.; Meng, X.M.; Jin, J. Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia. Front. Pharmacol. 2021, 12, 667753. [Google Scholar] [CrossRef] [PubMed]
  32. Jhang, J.J.; Ong, J.W.; Lu, C.C.; Hsu, C.L.; Lin, J.H.; Liao, J.W.; Yen, G.C. Hypouricemic effects of Mesona procumbens Hemsl. through modulating xanthine oxidase activity in vitro and in vivo. Food Funct. 2016, 7, 4239–4246. [Google Scholar] [CrossRef] [PubMed]
  33. Mehmood, A.; Zhao, L.; Ishaq, M.; Xin, W.; Zhao, L.; Wang, C.; Hossen, I.; Zhang, H.; Lian, Y.; Xu, M. Anti-hyperuricemic potential of stevia (Stevia rebaudiana Bertoni) residue extract in hyperuricemic mice. Food Funct. 2020, 11, 6387–6406. [Google Scholar] [CrossRef]
  34. Ma, L.; Hu, J.; Li, J.; Yang, Y.; Zhang, L.; Zou, L.; Gao, R.; Peng, C.; Wang, Y.; Luo, T.; et al. Bisphenol A promotes hyperuricemia via activating xanthine oxidase. FASEB J. 2018, 32, 1007–1016. [Google Scholar] [CrossRef] [PubMed]
  35. Preitner, F.; Bonny, O.; Laverrière, A.; Rotman, S.; Firsov, D.; Da Costa, A.; Metref, S.; Thorens, B. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc. Natl. Acad. Sci. USA 2009, 106, 15501–15506. [Google Scholar] [CrossRef]
  36. Xu, Y.; Cao, X.; Zhao, H.; Yang, E.; Wang, Y.; Cheng, N.; Cao, W. Impact of Camellia japonica Bee Pollen Polyphenols on Hyperuricemia and Gut Microbiota in Potassium Oxonate-Induced Mice. Nutrients 2021, 13, 2665. [Google Scholar] [CrossRef]
  37. Ichida, K.; Matsuo, H.; Takada, T.; Nakayama, A.; Murakami, K.; Shimizu, T.; Yamanashi, Y.; Kasuga, H.; Nakashima, H.; Nakamura, T.; et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat. Commun. 2012, 3, 764. [Google Scholar] [CrossRef]
  38. Wang, P.; Zhang, X.; Zheng, X.; Gao, J.; Shang, M.; Xu, J.; Liang, H. Folic Acid Protects against Hyperuricemia in C57BL/6J Mice via Ameliorating Gut-Kidney Axis Dysfunction. J. Agric. Food Chem. 2022, 70, 15787–15803. [Google Scholar] [CrossRef]
  39. Kim, S.M.; Lee, S.H.; Kim, Y.G.; Kim, S.Y.; Seo, J.W.; Choi, Y.W.; Kim, D.J.; Jeong, K.H.; Lee, T.W.; Ihm, C.G.; et al. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2015, 308, F993–F1003. [Google Scholar] [CrossRef]
  40. Zhou, Y.; Fang, L.; Jiang, L.; Wen, P.; Cao, H.; He, W.; Dai, C.; Yang, J. Uric acid induces renal inflammation via activating tubular NF-κB signaling pathway. PLoS ONE 2012, 7, e39738. [Google Scholar] [CrossRef]
  41. Fan, C.Y.; Wang, M.X.; Ge, C.X.; Wang, X.; Li, J.M.; Kong, L.D. Betaine supplementation protects against high-fructose-induced renal injury in rats. J. Nutr. Biochem. 2014, 25, 353–362. [Google Scholar] [CrossRef] [PubMed]
  42. Wang, S.; Fang, Y.; Yu, X.; Guo, L.; Zhang, X.; Xia, D. The flavonoid-rich fraction from rhizomes of Smilax glabra Roxb. ameliorates renal oxidative stress and inflammation in uric acid nephropathy rats through promoting uric acid excretion. Biomed. Pharmacother. 2019, 111, 162–168. [Google Scholar] [CrossRef]
  43. Wan, H.; Han, J.; Tang, S.; Bao, W.; Lu, C.; Zhou, J.; Ming, T.; Li, Y.; Su, X. Comparisons of protective effects between two sea cucumber hydrolysates against diet induced hyperuricemia and renal inflammation in mice. Food Funct. 2020, 11, 1074–1086. [Google Scholar] [CrossRef]
  44. Shin, N.R.; Whon, T.W.; Bae, J.W. Proteobacteria: Microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015, 33, 496–503. [Google Scholar] [CrossRef] [PubMed]
  45. Chen, Q.; Yin, Q.; Xie, Q.; Jiang, C.; Zhou, L.; Liu, J.; Li, B.; Jiang, S. 2′-Fucosyllactose Promotes the Production of Short-Chain Fatty Acids and Improves Immune Function in Human-Microbiota-Associated Mice by Regulating Gut Microbiota. J. Agric. Food Chem. 2022, 70, 13615–13625. [Google Scholar] [CrossRef]
  46. Huang, H.; Li, K.; Lee, Y.; Chen, M. Preventive Effects of Lactobacillus Mixture against Chronic Kidney Disease Progression through Enhancement of Beneficial Bacteria and Downregulation of Gut-Derived Uremic Toxins. J. Agric. Food Chem. 2021, 69, 7353–7366. [Google Scholar] [CrossRef]
  47. Yamada, N.; Iwamoto, C.; Kano, H.; Yamaoka, N.; Fukuuchi, T.; Kaneko, K.; Asami, Y. Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine. Nucleosides Nucleotides Nucleic Acids 2016, 35, 670–676. [Google Scholar] [CrossRef]
  48. Kilstrup, M.; Hammer, K.; Ruhdal Jensen, P.; Martinussen, J. Nucleotide metabolism and its control in lactic acid bacteria. FEMS Microbiol. Rev. 2005, 29, 555–590. [Google Scholar] [CrossRef] [PubMed]
  49. Wu, C.; Hu, Q.; Peng, X.; Luo, J.; Zhang, G. Marine Fish Protein Peptide Regulating Potassium Oxonate-Induced Intestinal Dysfunction in Hyperuricemia Rats Helps Alleviate Kidney Inflammation. J. Agric. Food Chem. 2023, 71, 320–330. [Google Scholar] [CrossRef] [PubMed]
  50. Ni, C.; Li, X.; Wang, L.; Li, X.; Zhao, J.; Zhang, H.; Wang, G.; Chen, W. Lactic acid bacteria strains relieve hyperuricaemia by suppressing xanthine oxidase activity via a short-chain fatty acid-dependent mechanism. Food Funct. 2021, 12, 7054–7067. [Google Scholar] [CrossRef]
  51. Hamer, H.M.; Jonkers, D.M.; Bast, A.; Vanhoutvin, S.A.; Fischer, M.A.; Kodde, A.; Troost, F.J.; Venema, K.; Brummer, R.J. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin. Nutr. 2009, 28, 88–93. [Google Scholar] [CrossRef]
Foods 14 03843 g001
Figure 1. UHPLC Q-Exactive Orbitrap MS analysis of DAE phytochemical composition. Positive ion chromatogram of DAE (A); anion chromatogram of DAE (B).
Figure 1. UHPLC Q-Exactive Orbitrap MS analysis of DAE phytochemical composition. Positive ion chromatogram of DAE (A); anion chromatogram of DAE (B).
Foods 14 03843 g001
Foods 14 03843 g002
Figure 2. DAE reduces serum uric acid levels and modulates physiological indicators in mice with HUA: serum uric acid (A); body weight (B); liver coefficients (C); and kidney coefficient (D). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Figure 2. DAE reduces serum uric acid levels and modulates physiological indicators in mice with HUA: serum uric acid (A); body weight (B); liver coefficients (C); and kidney coefficient (D). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Foods 14 03843 g002
Foods 14 03843 g003
Figure 3. DAE alleviated hepatic and renal damage in mice with HUA: alanine transaminase (A); aspartate transaminase (B); serum creatinine (C); blood urea nitrogen (D); H&E staining of the liver (E); and H&E staining of the kidney (F) (at a magnification of 200×). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group. The arrows show the apparent damage (black arrow: focal necrosis of hepatocytes; red arrow: focal infiltration of inflammatory cells; and blue arrow: inflammatory cell infiltration).
Figure 3. DAE alleviated hepatic and renal damage in mice with HUA: alanine transaminase (A); aspartate transaminase (B); serum creatinine (C); blood urea nitrogen (D); H&E staining of the liver (E); and H&E staining of the kidney (F) (at a magnification of 200×). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group. The arrows show the apparent damage (black arrow: focal necrosis of hepatocytes; red arrow: focal infiltration of inflammatory cells; and blue arrow: inflammatory cell infiltration).
Foods 14 03843 g003
Foods 14 03843 g004
Figure 4. DAE decreased XOD activities and modulated mRNA expression of urate transporters in mice with HUA: XOD inhibition in vitro (A); hepatic XOD activities (B); renal GLUT9 (C); OAT1 (D); OAT2 (E); ABCG2 (F); and ileal ABCG2 (G). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Figure 4. DAE decreased XOD activities and modulated mRNA expression of urate transporters in mice with HUA: XOD inhibition in vitro (A); hepatic XOD activities (B); renal GLUT9 (C); OAT1 (D); OAT2 (E); ABCG2 (F); and ileal ABCG2 (G). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Foods 14 03843 g004
Foods 14 03843 g005
Figure 5. DAE reduced the levels of renal inflammation cytokines in mice with HUA. Relative mRNA expression of IL-1β (A); IL-6 (B); TNF-α (C); TLR4 (D); MyD88 (E); NF-κB (F); NLRP3 (G); and Caspase-1 (H). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Figure 5. DAE reduced the levels of renal inflammation cytokines in mice with HUA. Relative mRNA expression of IL-1β (A); IL-6 (B); TNF-α (C); TLR4 (D); MyD88 (E); NF-κB (F); NLRP3 (G); and Caspase-1 (H). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Foods 14 03843 g005
Foods 14 03843 g006
Figure 6. DAE modulated gut microbiota disorder in mice with HUA: PCoA diagram (A); gut microbiota composition at the phylum (B) and genus (C) levels; LEfSe (D); Cladogram (E); and Tax4Fun analysis according to the KEGG database at level 2 (F) and level 3 (G).
Figure 6. DAE modulated gut microbiota disorder in mice with HUA: PCoA diagram (A); gut microbiota composition at the phylum (B) and genus (C) levels; LEfSe (D); Cladogram (E); and Tax4Fun analysis according to the KEGG database at level 2 (F) and level 3 (G).
Foods 14 03843 g006
Foods 14 03843 g007
Figure 7. Impact of DAE on SCFAs in Mice with HUA: acetic acid (A); propionic acid (B); and butyric acid (C). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Figure 7. Impact of DAE on SCFAs in Mice with HUA: acetic acid (A); propionic acid (B); and butyric acid (C). * p < 0.05 and ** p < 0.01: NC group vs. MC group; # p < 0.05 and ## p < 0.01: MC group vs. DAE group.
Foods 14 03843 g007
Foods 14 03843 g008
Figure 8. Correlation analysis of gut microbiota with SCFAs and HUA-related indicators. * p < 0.05; ** p < 0.01.
Figure 8. Correlation analysis of gut microbiota with SCFAs and HUA-related indicators. * p < 0.05; ** p < 0.01.
Foods 14 03843 g008
Table 1. UHPLC/Orbitrap–MS identification of main polyphenol compounds in DAE.
Table 1. UHPLC/Orbitrap–MS identification of main polyphenol compounds in DAE.
CompoundFormulaRt (min)Ionization ModeCalc Mw[M − H]− m/zDelta Mass [Da]MS/MS Fragment Ions m/z
Benzoic acidC7H6O29.771ESI−122.03539121.02811−0.0013993.0331; 121.0282
Caffeic acidC9H8O410.196ESI−180.0412179.03386−0.00106135.0439; 179.0341
Chlorogenic acidC16H18O99.729ESI−354.09459353.0874−0.0004985.0280; 191.0553
CynarosideC21H20O1113.029ESI+448.10021449.10748−0.00035153.0186; 287.0548
Quercetin-3β-D-glucosideC21H20O1212.93ESI+464.09545465.10251−0.00002271.0250; 300.0277; 301.0356; 463.0885
ApigetrinC21H20O1013.348ESI+432.10518433.11246−0.0004791.0544; 271.0601
DiosmetinC16H12O615.805ESI+300.06308301.07037−0.0003258.0514; 286.0471; 301.0697
4,5-Dicaffeoylquinic acidC25H24O1213.194ESI−516.12647515.1192−0.00031135.0439; 173.0446; 179.0341; 353.0879
Ferulic acidC10H10O410.299ESI−194.05697193.0497−0.00093134.0361; 149.0600; 178.0263; 193.0500
D-(-)-Quinic acidC7H12O69.729ESI−192.06242191.05515−0.0009785.0280; 191.0553
Neochlorogenic acidC16H18O98.2ESI−354.09468353.08734−0.00041135.0440; 179.0341; 191.0553; 353.0878
Gentisic acidC7H6O410.264ESI−154.02539153.01811−0.00122109.0281; 153.0182
KaempferolC15H10O612.683ESI+286.04701287.05429−0.00072212.1819; 287.0565
SchaftosideC26H28O1512.444ESI+580.1419581.14917−0.0009286.8080; 287.0557; 435.8592
LuteolinC15H10O622.725ESI−286.04771285.04044−0.00003133.0283; 285.0406
ReynoutrinC20H18O1113.452ESI+434.08449435.09171−0.0004269.5451; 153.0180; 303.0493
4-Hydroxyphenylacetic acidC8H8O39.496ESI−152.04618151.03886−0.0011671.0123; 89.0229; 101.0230; 151.0390
Biochanin AC16H12O517.065ESI+284.06818285.07538−0.000355.0550; 81.0706; 242.0573; 285.0754
ApocyninC9H10O311.199ESI+166.06284167.07011−0.0001678.0469; 79.0547; 167.0705
3,4-DihydroxybenzaldehydeC7H6O38.417ESI+138.03163139.03891−0.0000665.0394; 93.0340; 111.0444; 139.0393
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhou, X.; Liu, T.; Xu, B.; Zhang, W.; Li, X.; Wei, F.; Lv, H.; Ji, X.; Zhang, B.; Wang, S. Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes. Foods 2025, 14, 3843. https://doi.org/10.3390/foods14223843

AMA Style

Zhou X, Liu T, Xu B, Zhang W, Li X, Wei F, Lv H, Ji X, Zhang B, Wang S. Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes. Foods. 2025; 14(22):3843. https://doi.org/10.3390/foods14223843

Chicago/Turabian Style

Zhou, Xiaofei, Tianxu Liu, Bingye Xu, Weiqian Zhang, Xiang Li, Fan Wei, Huan Lv, Xuemeng Ji, Bowei Zhang, and Shuo Wang. 2025. "Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes" Foods 14, no. 22: 3843. https://doi.org/10.3390/foods14223843

APA Style

Zhou, X., Liu, T., Xu, B., Zhang, W., Li, X., Wei, F., Lv, H., Ji, X., Zhang, B., & Wang, S. (2025). Dandelion Leaf Aqueous Extract Relieves Hyperuricemia and Its Complications via Modulating Uric Acid Metabolism, Renal Inflammation, and Gut Microbes. Foods, 14(22), 3843. https://doi.org/10.3390/foods14223843

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop